Academic conferences

Tempus Announces Eleven Abstracts Accepted for Presentation at the 2021 American Society of Clinical Oncology Annual Meeting

Retrieved on: 
Tuesday, June 1, 2021
Technology, Genetics, Clinical trials, Software, Biotechnology, Health, Pharmaceutical, Data management, Oncology, Articles, Education, Academic conferences, Academia, Academic publishing, Asco, Poster session, American Society of Clinical Oncology, Abstract

Tempus , a leader in artificial intelligence and precision medicine, today announced eleven abstracts accepted for presentation at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting taking place virtually from June 4 - 8.

Key Points: 
  • Tempus , a leader in artificial intelligence and precision medicine, today announced eleven abstracts accepted for presentation at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting taking place virtually from June 4 - 8.
  • One abstract selected for oral presentation and four abstracts selected for poster presentation at ASCO 2021 are highlighted below.
  • The complete list of Tempus-affiliated abstracts and poster presentations can be found at www.tempus.com/publications .
  • This abstract has been accepted for oral presentation in the Gastrointestinal CancerGastroesophageal, Pancreatic, and Hepatobiliary session on June 5 from 1:45 - 4:45 pm CDT.

GBT Announces Upcoming Data Presentations at European Hematology Association (EHA) 2021 Virtual Congress

Retrieved on: 
Wednesday, May 12, 2021
Articles, Education, Clinical medicine, Academic conferences, EHA, Academic publishing, European Hematology Association, Voxelotor, Poster session, Abstract, Sickle cell disease

b'SOUTH SAN FRANCISCO, Calif., May 12, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that six abstracts related to its sickle cell disease (SCD) programs will be presented at the European Hematology Association (EHA) 2021 Virtual Congress , taking place online June 9-17, 2021.

Key Points: 
  • b'SOUTH SAN FRANCISCO, Calif., May 12, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that six abstracts related to its sickle cell disease (SCD) programs will be presented at the European Hematology Association (EHA) 2021 Virtual Congress , taking place online June 9-17, 2021.
  • \xe2\x80\x9cWe are encouraged by the extensive body of new data being presented at this year\xe2\x80\x99s EHA Congress, supporting the use of Oxbryta in both real-world and clinical trial settings.
  • All oral and poster presentations will be available on the EHA website on Friday, June 11, at 9:00 a.m. CEST/3:00 a.m. EDT.
  • Other abstracts to be presented include real-world evidence supporting the use of Oxbryta in patients ages 12 and older.

Capture Higher Ed Announces National Virtual Conference - INNOVATE 2021

Retrieved on: 
Wednesday, April 21, 2021
Microsoft, Articles, Conferences, Academic conferences, LinkedIn, Recruitment, Twitch, TED

b'LOUISVILLE, Ky., April 21, 2021 /PRNewswire-PRWeb/ -- With the theme "clarity and creativity," Capture Higher Ed is convening higher education enrollment and marketing professionals, June 16 and 17, for INNOVATE 2021 a free, national, virtual conference packed with insightful and inspirational keynote sessions, panel discussions, presentations and interactive workshops.\n"We\'re excited to build upon last year\'s highly successful INNOVATE conference, which drew nearly 400 participants from more than 135 institutions from 38 states," says Capture CEO Leonard Napolitano.

Key Points: 
  • b'LOUISVILLE, Ky., April 21, 2021 /PRNewswire-PRWeb/ -- With the theme "clarity and creativity," Capture Higher Ed is convening higher education enrollment and marketing professionals, June 16 and 17, for INNOVATE 2021 a free, national, virtual conference packed with insightful and inspirational keynote sessions, panel discussions, presentations and interactive workshops.\n"We\'re excited to build upon last year\'s highly successful INNOVATE conference, which drew nearly 400 participants from more than 135 institutions from 38 states," says Capture CEO Leonard Napolitano.
  • "We want INNOVATE 2021 attendees to leave the conference with clear and creative tactics they can apply immediately to the recruitment and marketing efforts at their institutions.
  • By streaming on five platforms YouTube Live, Twitch, Periscope, LinkedIn Live and Facebook Live Capture is removing any barriers for the broader higher ed community to access the the conference\'s sessions and materials.
  • Founded in 2011, Capture has served hundreds of higher education institutions and programs across the country while being recognized by Inc. 5000 as a fastest-growing U.S. company.\n'

Progenity to Present Key Prospective Verification Study Data for its Preeclampsia Rule-Out Test at 2021 American College of Obstetricians and Gynecologists Annual Meeting

Retrieved on: 
Thursday, April 8, 2021
Articles, Biomarkers, Academic conferences, Biotechnology, Chemical pathology, Poster session, Biology, Life sciences

The data presented will be a part of the virtual meetings interactive ePosters.

Key Points: 
  • The data presented will be a part of the virtual meetings interactive ePosters.
  • Details of the presentation are as follows:
    Title Performance of a novel multi-biomarker rule out preeclampsia test: a prospective verification study
    ACOG anticipates publishing abstracts and posters the week of April 26th.
  • The poster presentation will also be made available on the Progenity website following the conference.
  • Progenity providesin vitromolecular tests designed to improve lives by providing actionable information that helps guide patients and physicians in making medical decisions during key life stages.

Tempus Announces Abstracts to be Presented at the American Association of Cancer Research Annual Meeting 2021

Retrieved on: 
Wednesday, April 7, 2021
Biotechnology, Health, Genetics, Pharmaceutical, Oncology, Articles, Education, Academia, Academic publishing, Academic conferences, Publishing, American Association for Cancer Research, Abstract, Poster session, Biotechnology, Health, Genetics, Pharmaceutical, Oncology, Articles, Education, Academia, Academic publishing, Academic conferences, Publishing, American Association for Cancer Research, Abstract, Poster session

Tempus, a leader in artificial intelligence and precision medicine, today announced abstracts accepted for poster presentation at the American Association for Cancer Research (AACR) Annual Meeting 2021 , which will convene virtually on April 10-15 and May 17-21.

Key Points: 
  • Tempus, a leader in artificial intelligence and precision medicine, today announced abstracts accepted for poster presentation at the American Association for Cancer Research (AACR) Annual Meeting 2021 , which will convene virtually on April 10-15 and May 17-21.
  • The research leverages Tempus unparalleled library of multi-modal data to facilitate discovery, development, and delivery of optimized therapeutic options for patients.
  • As evidenced by the collection of abstracts, we are utilizing data-driven tools that empower physicians to optimize patient care.
  • Four of the abstracts accepted for poster presentation at AACR 2021 are highlighted below and the complete list can be found at www.tempus.com/publications .

Allakos Announces Multiple Presentations Related to Eosinophil and Mast Cell-Driven Diseases at the 2021 DDW Annual Meeting

Retrieved on: 
Tuesday, March 30, 2021
DDW, Academic conferences, Poster session

REDWOOD CITY, Calif., March 30, 2021 (GLOBE NEWSWIRE) -- Allakos Inc. (the Company or Allakos) (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) for the treatment of eosinophil and mast cell-related diseases, today announced the acceptance of two oral and five poster presentations at the upcoming Digestive Disease Week (DDW) Annual Meeting.

Key Points: 
  • REDWOOD CITY, Calif., March 30, 2021 (GLOBE NEWSWIRE) -- Allakos Inc. (the Company or Allakos) (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) for the treatment of eosinophil and mast cell-related diseases, today announced the acceptance of two oral and five poster presentations at the upcoming Digestive Disease Week (DDW) Annual Meeting.
  • The presentations will take place during the DDW Annual Meeting being held virtually from May 21 to 23, 2021, at which time ePosters and ePapers will be available from the DDW ePosters and ePapers website.
  • Abstracts will be available on the ePosters and ePapers website in April, and in the May online supplement to Gastroenterology.
  • Patients with Functional Bowel Symptoms: A Real Life Experience (Kathryn Peterson MD)

Pittcon 2021 Virtual Program Eclipses 1,350 Presentations

Retrieved on: 
Wednesday, January 27, 2021
Education in Pennsylvania, Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, Academic conferences, Poster session

PITTSBURGH, Jan. 27, 2021 /PRNewswire/ --Pittcon is pleased to announce that its 2021 Technical Program has eclipsed 1,350 presentations, comprised of symposia, invited and organized sessions, contributed sessions, and oral and poster sessions.

Key Points: 
  • PITTSBURGH, Jan. 27, 2021 /PRNewswire/ --Pittcon is pleased to announce that its 2021 Technical Program has eclipsed 1,350 presentations, comprised of symposia, invited and organized sessions, contributed sessions, and oral and poster sessions.
  • This year, for the first time in the conference's over 71-year history, the Pittcon Technical Program will be presented completely via virtual platform.
  • "We are elated to have such a tremendous response to participate in our technical program this year," states Neal Dando, Ph.D., Pittcon 2021 President.
  • The Wallace H. Coulter Lecture is the annual keynote talk at Pittcon and an integral part of the Pittcon Technical Program.

SIUE's Luo Hosts Successful International Conference Online

Retrieved on: 
Thursday, December 10, 2020
Articles, Academic conferences, Academic conference, TED, Conference

According to Luo, among the positives of the online format was attendees' ability to access presentations as convenient in various time zones.

Key Points: 
  • According to Luo, among the positives of the online format was attendees' ability to access presentations as convenient in various time zones.
  • "The conference organization committee shared the videos on YouTube, which accommodated the time zones of local symposium organizers," Luo explained.
  • "Participants liked the conference style, as they could efficiently discuss problems to resolve their puzzles in research.
  • The online format saved people both time and cost, while still achieving our goals of research communication and international networking.

Progenity to Present at 2020 San Antonio Breast Cancer Virtual Symposium

Retrieved on: 
Tuesday, November 17, 2020
Academic conferences, Poster session, Presentation, Research, Breast cancer, Articles

SAN DIEGO, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Progenity , Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, will be presenting at the San Antonio Breast Cancer Virtual Symposium (SABCS) set to take place December 8-11, 2020.

Key Points: 
  • SAN DIEGO, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Progenity , Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, will be presenting at the San Antonio Breast Cancer Virtual Symposium (SABCS) set to take place December 8-11, 2020.
  • The data presented will be a part of the events Spotlight Session Poster Presenters.
  • The poster presentation will also be made available on the Progenity website following the conference.
  • Progenity provides in vitro molecular tests designed to improve lives by providing actionable information that helps guide patients and physicians in making medical decisions during key life stages.

Progenity to Present Precision Medicine Abstracts at American College of Gastroenterology (ACG) Virtual Annual Meeting in October

Retrieved on: 
Friday, October 9, 2020
Articles, Education, Academic conferences, Policy, Academic publishing, Poster session, Research, Abstract, Precision medicine, Biotechnology, Lluís Companys, Presentation

Progenity will be presenting one oral presentation and one poster presentation.

Key Points: 
  • Progenity will be presenting one oral presentation and one poster presentation.
  • More information about these abstracts will be made available on the Progenity website following the conference.
  • Progenity, Inc. is a biotechnology company with an established track record of success in developing and commercializing molecular testing products, as well as innovating in the field of precision medicine.
  • For additional information about Progenity, please visit the companys website at www.progenity.com .